NEXTURNBIOSCIENCE Statistics

Total Valuation

NEXTURNBIOSCIENCE has a market cap or net worth of KRW 31.97 billion. The enterprise value is 82.83 billion.

Market Cap	31.97B
Enterprise Value	82.83B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

NEXTURNBIOSCIENCE has 11.28 million shares outstanding. The number of shares has increased by 21.97% in one year.

Current Share Class	n/a
Shares Outstanding	11.28M
Shares Change (YoY)	+21.97%
Shares Change (QoQ)	+2.90%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	3.38%
Float	8.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.81
PB Ratio	0.22
P/TBV Ratio	0.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.51
EV / Sales	2.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.88

Financial Position

The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.57.

Current Ratio	2.10
Quick Ratio	1.55
Debt / Equity	0.57
Debt / EBITDA	90.78
Debt / FCF	-13.82
Interest Coverage	-0.20

Financial Efficiency

Return on equity (ROE) is -15.51% and return on invested capital (ROIC) is -0.29%.

Return on Equity (ROE)	-15.51%
Return on Assets (ROA)	-0.26%
Return on Capital (ROIC)	-0.29%
Revenue Per Employee	629.08M
Profits Per Employee	-414.55M
Employee Count	57
Asset Turnover	0.14
Inventory Turnover	3.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.60%
50-Day Moving Average	3,665.10
200-Day Moving Average	3,554.28
Relative Strength Index (RSI)	37.88
Average Volume (20 Days)	233,767

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NEXTURNBIOSCIENCE had revenue of KRW 35.86 billion and -23.63 billion in losses. Loss per share was -2,368.70.

Revenue	35.86B
Gross Profit	7.94B
Operating Income	-1.07B
Pretax Income	-25.77B
Net Income	-23.63B
EBITDA	908.09M
EBIT	-1.07B
Loss Per Share	-2,368.70

Full Income Statement

Balance Sheet

The company has 31.57 billion in cash and 82.44 billion in debt, giving a net cash position of -50.87 billion or -4,510.96 per share.

Cash & Cash Equivalents	31.57B
Total Debt	82.44B
Net Cash	-50.87B
Net Cash Per Share	-4,510.96
Equity (Book Value)	143.95B
Book Value Per Share	12,765.79
Working Capital	26.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.14 billion and capital expenditures -824.87 million, giving a free cash flow of -5.97 billion.

Operating Cash Flow	-5.14B
Capital Expenditures	-824.87M
Free Cash Flow	-5.97B
FCF Per Share	-529.18

Full Cash Flow Statement

Margins

Gross margin is 22.15%, with operating and profit margins of -2.98% and -65.90%.

Gross Margin	22.15%
Operating Margin	-2.98%
Pretax Margin	-71.87%
Profit Margin	-65.90%
EBITDA Margin	2.53%
EBIT Margin	-2.98%
FCF Margin	n/a

Dividends & Yields

NEXTURNBIOSCIENCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.97%
Shareholder Yield	-21.97%
Earnings Yield	-83.55%
FCF Yield	-18.67%

Stock Splits

The last stock split was on April 12, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Apr 12, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

NEXTURNBIOSCIENCE has an Altman Z-Score of 0.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.8
Piotroski F-Score	n/a